NCT02617472

Brief Summary

This study will assess the effectiveness of a new pelvic floor exercise device in strengthening pelvic floor muscles and treating urinary incontinence among women who are experiencing symptoms of pelvic floor weakness. The study will be conducted over 12 weeks and results will be collected through self-assessment questionnaires and clinical pelvic examination. Effectiveness outcomes will be tracked over the duration of the trial and measured against historical symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2015

Completed
2 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 1, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

August 14, 2017

Status Verified

August 1, 2017

Enrollment Period

1.7 years

First QC Date

October 30, 2015

Last Update Submit

August 10, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in pelvic floor strength

    Pelvic floor strength measured by a clinical perineometer in cm H2O. A baseline measurement of resting and peak muscle contraction values will be recorded at the start before the intervention and after the 12 weeks of treatment.

    12 weeks

Secondary Outcomes (2)

  • Frequency of bladder leaks.

    12 weeks

  • Volume of bladder leaks

    12 weeks

Other Outcomes (2)

  • Subjective assessment of vaginal tightness

    12 weeks

  • Subjective assessment of sexual sensations

    12 weeks

Study Arms (1)

Pelvic floor exercise

EXPERIMENTAL

Pelvic floor exerciser, daily use

Device: Pelvic floor exerciser

Interventions

Daily exercise using the study device

Also known as: KegelSmart pelvic floor trainer
Pelvic floor exercise

Eligibility Criteria

Age20 Years - 69 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject provides written informed consent and HIPAA authorization before any study procedures are conducted;
  • Experience urinary incontinence and/or vaginal laxity and/or decreased sexual sensation for a period of 6 weeks or more.

You may not qualify if:

  • Subject has any condition or exhibits behavior that indicates to the Principal Investigator that the Subject is unlikely to be compliant with study procedures and visits
  • Has had prior surgery for incontinence, prolapse or vaginal tightening
  • Has been diagnosed with pelvic organ prolapse more severe than grade 2
  • Suffers from vaginal penetration difficulties
  • Has had more than 3 urinary tract infections in the past 12 months
  • Has any conditions of the bladder that effect continence
  • Suffer from vaginal/vulvar/pelvic pain
  • Is currently taking any medication for incontinence
  • Is pregnant or trying to become pregnant
  • Has given birth less than 6 weeks prior to enrollment
  • Has been diagnosed obese - BMI \> 30
  • Is a heavy smoker - \> 20 cigarettes per day
  • Has a history of neurological conditions - Parkinson's, multiple sclerosis and other
  • Suffers from chronic constipation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Banner University Medical Center

Phoenix, Arizona, 85006, United States

Location

MeSH Terms

Conditions

Urinary Incontinence, StressSexual Dysfunction, Physiological

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Diseases

Study Officials

  • Debra Wickman, MD

    FACOG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2015

First Posted

December 1, 2015

Study Start

November 1, 2015

Primary Completion

July 1, 2017

Study Completion

August 1, 2017

Last Updated

August 14, 2017

Record last verified: 2017-08

Locations